← Eichor
Condition: Obesity Drug Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Obesity Drug

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
NA · 2 location(s) · University of Texas at Austin · NCT07480109Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet
Phase 4 · 1 location(s) · Laval University · NCT06620562Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study
NA · 1 location(s) · Universidad Católica San Antonio de Murcia · NCT07447362A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment
NA · 5 location(s) · Karolinska Institutet · NCT04917601Real-World Case Registry Study on Obesity
Phase N/A · 1 location(s) · Hubei Hospital of Traditional Chinese Medicine · NCT07448090Metformin as Adjunct Therapy in Depression-Obesity Comorbidity: Clinical and Genetic Evaluation
NA · 2 location(s) · Riphah International University · NCT07654179Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
NA · 1 location(s) · Indiana University · NCT07119658Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
NA · 1 location(s) · Johns Hopkins University · NCT07396805Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
NA · 3 location(s) · Ariel University · NCT06431308Study of Patients Being Treated With Anti-obesity Medication
Phase N/A · 1 location(s) · Texas Tech University · NCT06790160Comorbid Obesity and Depression With an Anti-inflammatory Medication
NA · 1 location(s) · King's College London · NCT06537921A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Phase 3 · 25 location(s) · Pfizer · NCT07595549A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepati
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT07364175The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication
NA · 1 location(s) · University of Pittsburgh · NCT07652333Cooking Classes as a Family-based Intervention for Weight Reduction: Effects on Dietary Quality and Weight Management in
NA · 1 location(s) · Institute for Healthier Living Abu Dhabi · NCT07675148HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking
NA · 4 location(s) · Karolinska Institutet · NCT06952348Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
Phase N/A · 1 location(s) · Xijing Hospital · NCT07180368Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
Phase 1 · 1 location(s) · Gan & Lee Pharmaceuticals. · NCT07128888A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · 147 location(s) · Novo Nordisk A/S · NCT06717698Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semagluti
Phase N/A · 2 location(s) · Hospital Italiano de Buenos Aires · NCT07621419Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
NA · 1 location(s) · West Virginia School of Osteopathic Medicine · NCT06049420AP Metabolism Transcriptomics
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT06814314AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Wei
Phase 3 · 72 location(s) · Novo Nordisk A/S · NCT07339423FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Phase 2 · 4 location(s) · University of Illinois at Chicago · NCT07332741Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
Phase 1 · 4 location(s) · OrsoBio, Inc · NCT05822544Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
Phase 1/Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06703788A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07437079Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity
NA · 1 location(s) · National Taiwan Sport University · NCT07540949Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
NA · 1 location(s) · Laval University · NCT03302195Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
NA · 1 location(s) · Kazakh Academy of Nutrition · NCT07728669
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.